Search Medical Condition
Please enter condition
Please choose location
 

Wloclawek, Poland Clinical Trials

A listing of Wloclawek, Poland clinical trials actively recruiting patients volunteers.

RESULTS

Found (6) clinical trials

An Efficacy and Safety Study of LYC-30937-EC in Subjects With Active Ulcerative Colitis

Approximately 120 subjects will be randomized to receive either enteric-coated LYC-30937-EC 25 mg PO QD or matching placebo PO QD for the duration of 8 weeks. Randomization will be stratified based on previous exposure to anti-TNF agents such that at least 50% of the randomized subjects will be anti-TNF naïve ...

Phase

0.77 miles

Learn More »

Safety and Efficacy Study of JNJ-64304500 in Participants With Moderately to Severely Active Crohn's Disease

The purpose of the study is to assess the safety and efficacy of JNJ-64304500 in participants with moderately to severely active Crohn's disease.

Phase

0.77 miles

Learn More »

Registrational Study With Omecamtiv Mecarbil/AMG 423 to Treat Chronic Heart Failure With Reduced Ejection Fraction

The purpose of this study is to determine if treatment with omecamtiv mecarbil/AMG 423 when added to standard of care is well tolerated and superior to placebo in reducing the risk of cardiovascular death or heart failure events in subjects with chronic HFrEF.

Phase

0.77 miles

Learn More »

Study to Compare Oral PF-06651600 PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis

The purpose of this study is to determine whether PF-06651600 and PF-06700841 are effective in treatment of moderate to severe ulcerative colitis.

Phase

0.77 miles

Learn More »

Safety of Fentanyl TAIFUN Treatment

A Multicenter, Multinational, Randomized, Open-Label, Parallel-Group Trial to Evaluate hte Safety of Fentanyl TAIFUN Treatment after titrated Dose Administration and the Current Breakthrough Pain Treatment for Breakthrough Pain in Cancer Patients on Maintenance Opioid Therapy

Phase

1.56 miles

Learn More »

Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis

This is a Phase II multi-centre, double blind, randomised, placebo-controlled, clinical study to evaluate the efficacy, safety, and tolerability of an oral peptide, PTG-100, administered as capsules for 12 weeks in subjects with moderate to severe UC. Following screening procedures and confirmation of subject eligibility, subjects will be randomised 1:1:1:1 ...

Phase

4.93 miles

Learn More »